TCL Archive Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial June 1, 2001
TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001
